PURPOSE: To investigate the effect of gemcitabine (dFdC), a promising radiosensitizing nucleoside analog, on the induction and repair of DNA double-strand breaks (dsbs) after ionizing radiation (RT) in a pancreatic tumor cell line. MATERIAL AND METHODS: BxPC3 pancreatic tumor cells were treated using different concentrations of gemcitabine with and without subsequent irradiation. DNA dsbs were detected by constant-field gel electrophoresis under neutral conditions. RESULTS: With the addition of gemcitabine (0.5-1,000 micromol/l for 2 h prior to RT) to RT (0-75 Gy), a considerable and dose-dependent increase of remaining DNA damage after 24 h (5.4-fold for 0.5 micromol/l dFdC, 12.2-fold for 1,000 micromol/l dFdC at 25 Gy) was noted. Enhancement factors were inversely correlated with increasing X-ray dose (7.8-fold for 0.5 micromol/l at 1 Gy decreasing to 1.6-fold at 75 Gy). Conversely, the induction of DNA dsbs was not affected. Gemcitabine alone lead to a slight increase of initial DNA dsbs and only a modest elevation of residual DNA damage. CONCLUSION: These findings strengthen the hypothesis of DNA repair inhibition as a major mechanism of radiosensitization by gemcitabine.
PURPOSE: To investigate the effect of gemcitabine (dFdC), a promising radiosensitizing nucleoside analog, on the induction and repair of DNA double-strand breaks (dsbs) after ionizing radiation (RT) in a pancreatic tumor cell line. MATERIAL AND METHODS: BxPC3 pancreatic tumor cells were treated using different concentrations of gemcitabine with and without subsequent irradiation. DNA dsbs were detected by constant-field gel electrophoresis under neutral conditions. RESULTS: With the addition of gemcitabine (0.5-1,000 micromol/l for 2 h prior to RT) to RT (0-75 Gy), a considerable and dose-dependent increase of remaining DNA damage after 24 h (5.4-fold for 0.5 micromol/l dFdC, 12.2-fold for 1,000 micromol/l dFdC at 25 Gy) was noted. Enhancement factors were inversely correlated with increasing X-ray dose (7.8-fold for 0.5 micromol/l at 1 Gy decreasing to 1.6-fold at 75 Gy). Conversely, the induction of DNA dsbs was not affected. Gemcitabine alone lead to a slight increase of initial DNA dsbs and only a modest elevation of residual DNA damage. CONCLUSION: These findings strengthen the hypothesis of DNA repair inhibition as a major mechanism of radiosensitization by gemcitabine.
Authors: C Blattmann; S Oertel; M Thiemann; K J Weber; P Schmezer; O Zelezny; R Lopez Perez; A E Kulozik; J Debus; V Ehemann Journal: Strahlenther Onkol Date: 2012-01-18 Impact factor: 3.621
Authors: Frank Michael Klenke; Amir Abdollahi; Marc Bischof; Martha-Maria Gebhard; Volker Ewerbeck; Peter E Huber; Axel Sckell Journal: Strahlenther Onkol Date: 2010-12-23 Impact factor: 3.621
Authors: Natasja Castro Kreder; Chris Van Bree; Nicolaas A P Franken; Jaap Haveman Journal: J Cancer Res Clin Oncol Date: 2003-08-29 Impact factor: 4.553
Authors: Priyanka Gupta; Stella Totti; Pedro A Pérez-Mancera; Eleanor Dyke; Andrew Nisbet; Giuseppe Schettino; Roger Webb; Eirini G Velliou Journal: RSC Adv Date: 2019-12-17 Impact factor: 4.036
Authors: Pankaj Chaudhary; Thomas I Marshall; Frederick J Currell; Andrzej Kacperek; Giuseppe Schettino; Kevin M Prise Journal: Int J Radiat Oncol Biol Phys Date: 2015-07-29 Impact factor: 7.038